Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The commercial genetic testing landscape for Parkinson's disease.

Parkinsonism & related disorders - 1 Nov 2021

Cook Lola, Schulze Jeanine, Verbrugge Jennifer, Beck James C, Marder Karen S, Saunders-Pullman Rachel, Klein Christine, Naito Anna, Alcalay Roy N

Abstract excerpt

INTRODUCTION: There have been no specific guidelines regarding which genes should be tested in the clinical setting for Parkinson's disease (PD) or parkinsonism. We evaluated the types of clinical genetic testing offered for PD as the first step of our gene curation. METHODS: The National Institutes of Health (NIH) Genetic Testing Registry (GTR) was queried on 12/7/2020 to identify current commercial PD genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Nuclear Receptors and Signaling

Share to Parkinson Disease

Share to Parkinson's Disease Mechanisms and Treatments

Source

Open in PubMed Open full text

Identifiers

PMID: 34696975
DOI: 10.1016/j.parkreldis.2021.10.001
PMCID: PMC8633166

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The commercial genetic testing landscape for Parkinson's disease.PMID 34696975Read ↗

Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study.Semantic proximity Read ↗

Genetic Testing in Parkinson's DiseaseSemantic proximity Read ↗

Genetics of Parkinson's Disease: state-of-the-art and role in clinical settings.Semantic proximity Read ↗

Global Parkinson’s Genetics Program (GP2) Monogenic Network Protocol: Elucidating causative gene variants in hereditary Parkinson’s diseaseSemantic proximity Read ↗

Genome sequencing in the Parkinson’s disease clinicSemantic proximity Read ↗

PD GENEration: An International Parkinson’s Disease Genetic Research StudySemantic proximity Read ↗

The Role of Genetic Testing for Parkinson's Disease.Semantic proximity Read ↗

A multicenter study of genetic testing for Parkinson’s disease in the clinical settingSemantic proximity Read ↗

Implications of genetics on the diagnosis and care of patients with Parkinson disease.Semantic proximity Read ↗

Genetics of Parkinson's Disease: From Causes to Treatment.Semantic proximity Read ↗

Genetic testing in Parkinson disease: promises and pitfalls.Semantic proximity Read ↗

RETRACTED: A systematic genomic screen of 755 early-onset Parkinson’s patients from the 100,000 Genomes Project increases diagnostic yield and directs clinical pathwaysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.